Zydus Lifesciences Limited — Updates, 10-08-2026: Press Release
10-08-2026 | 03:19 pm
10-08-2026 | 03:19 pm
Zydus Lifesciences launched REVAHALE™, India’s first once-daily nebulised LAMA for COPD. This innovative drug offers sustained 24-hour bronchodilation, addressing critical patient needs and potentially boosting market share in the respiratory segment.
No comments yet. Be the first to comment!
